Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs

HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protective efficacy, and non-replicative status of the high...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Bernard, Marie-Clotilde, Barban, Véronique, Pradezynski, Fabrine, de Montfort, Aymeric, Ryall, Robert, Caillet, Catherine, Londono-Hayes, Patricia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383384/
https://ncbi.nlm.nih.gov/pubmed/25837802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0121518
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi